Raimund Peter is an accomplished executive in the field of pharmacokinetics and pharmacometrics, currently serving as Executive Director – Global PK/PD & Pharmacometrics at Eli Lilly and Company since December 2022. Previous leadership roles include Senior Director Clinical Pharmacology at NuCana plc, Senior Director at Mission Therapeutics overseeing Clinical Pharmacology & Pharmacometrics, and Director at TENARON Ltd, providing consulting for the pharma industry. Additional experience includes leadership positions at AiCuris Anti-infective Cures AG, AstraZeneca, and Novartis, contributing to significant advancements in drug development. Raimund Peter holds a Ph.D. in Chemistry with a focus on Biochemical Pharmacology & Toxicology from the University of Washington and an earlier education from FAU Erlangen-Nürnberg.
This person is not in the org chart
This person is not in any teams
This person is not in any offices